+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Point-of-Care/POC Lipid Testing Market 2017-2022: Supplier Shares, Competitive Strategies, Country Segment Forecasts - Physician Offices, Emergency Rooms, Ambulatory Care Centers

  • ID: 4040515
  • Report
  • Region: Global
  • 305 pages
  • VPG Market Research
1 of 2

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Decode Genetics
  • Fujirebio
  • Lonza
  • Roche
  • MORE

Point-of-Care/POC Lipid Testing Market 2017-2022: Supplier Shares, Competitive Strategies, Country Segment Forecasts - Physician Offices, Emergency Rooms, Ambulatory Care Centers - Innovative Technologies, Instrumentation Review, Emerging Opportunities

This new 305-page report contains 22 tables, and provides a comprehensive analysis of thePOC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market.

Rationale:

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

  • Physician Offices/Group Practices
  • Emergency Rooms
  • Ambulatory Care Centers

Competitive Assessments:

Assessments of major POC suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations:

  • Specific opportunities for new instruments and reagent systems with potentially significant market appeal during the next five years.
  • Design criteria for POC testing products.
  • Alternative business expansion strategies.
  • Potential market entry barriers and risks.

Methodology:

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.

Contains 305 pages and 22 tables

Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
  • Abbott
  • Accriva
  • ADI/American Diagnostica
  • Agilent Technologies
  • Alere/Biosite/Inverness
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Biomerieux
  • Bio-Rad
  • Cepheid
  • Chrono-Log
  • Corgenix
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • Diagnostica Stago/Trinity Biotech
  • Diamedix
  • Diasorin
  • Eiken Chemical
  • EKF Diagnostics
  • Fujirebio
  • Grifols
  • Helena Laboratories
  • Hologic/Gen-Probe
  • Horiba
  • Instrumentation Laboratory
  • Kreatech/Leica
  • Kyowa Medex
  • Lonza
  • Mackay Life Sciences
  • Matritech
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Polartechnics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sequenom
  • Siemens
  • Sienco
  • Sysmex
  • Takara Bio
  • Thermo Fisher
  • Tosoh
  • Wako
  • Zycare/Alere
Note: Product cover images may vary from those shown
Adroll
adroll